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PORPHYRIA-AN "ENZYME LESION" 
REVIEW OF BASIC AND CLINICAL ASPECTS 
W. J. T R E A N O R . M . D . — C . E . R U P E , M . D . * 
As knowledge of cellular bio-chemislrj increases, physicians have more and more 
begun to think of disease processes in terms of defects or alterations in thc myriad 
>'i chemical reactions wi lh in the cell. We hear now in discussions of diseases such as 
I ushing's disease, pernicious anemia, gout and adrenogenital svndrome. ihe lerm 
enzyme lesion" or enzymatic defects. The term "enzjme lesion" was coined by Gerti 
( ori who described the first one complelely und:;rslood — glycogen storage disease. 
, \n intimate knowledge of bio-chemislrv is becoming as valuable a tool in clinical 
medicine as the stethoscope or palpating hand. The disease here presenied, acule 
inlermilienl porph\r ia , alfords an opportuniiy to review lhc imporlanl metabolism of a 
•Zioup of chemical compounds known as lhc porphyrins. The porphyrins are much more 
iLiiportanl Ihan porphyria. Porphyria is very uncommon, whereas Ihe porphyrins are 
iiporianl in the cellular activiiy ot all the cells of the body. 
The porphyrins comprise a large class of pigmenls, and the exact chemical 
I, ' i isli lution of the majori iy of them is unknown. Porphyrins are found throughout the 
. iimal and yegetable kingdom. Chlorophyll , for example, intimately involved in photo-
s\nthesis, is a porphyrin containing magnesium. A i l the porphyrins conlain the 
inirphin nucleus as their basic struclure. Porphin may he synthesized, but it is purely 
a laboratory creation and does not exist in nature. I t is composed of four pyrrole rings 
connected bv four methene bridges. By the addition of side chains on carbon atoms 
1 Ihrough 8. all the porphyrins may be represented. 
PORPHIN PORPHIN (SHORTHAND 
REPRESENTATION) 
F I G U R E 1 — BASIC C O M P O U N D P O R P H I N 
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In ligurel I the basic compound porphin is represented. To simplify its representa-
tion the shorthand method of Fischer is usually used as shown. The porphyrins which 
demand our interest in clinical medicine, and whose structure will be shown, are 
protoporphyrin, coproporphyrin and uroporphyrin.' These compounds are important 
only because Ihey are inlcmiediales in the production of the metalloporphyrins — hemo-
globin, oxidases, catalases, peroxidases and cytochromes, all of which are respiratory 
enz\mcs. It should be emphasized that uroporphyrin, coproporphyrin and protoporphy-
rin are steps in the synthesis of the metalloporphyrins and are not breakdown products. 
The question arises regarding the numbering of the porphyrins. For example, 
we read of uroporphyrin 1 and uroporphyrin 111. The numbering has its origin in the 
classic work of Hans Fischer, who in 1937 synthesized a basic porphyrin compound 
which he called etioporphyrin, a tetramethyltelraelhyl porphyrin, (again only a syn-
thetic compound). This is represented in figure II using the shorthand symbol of 
Fischer for the porphyrin nucleus and showing the four possible isomers. Any porphyrin 
having just 2 different side chains and 4 of each has only 4 possible isomers. 
M Methyl (CHj) E Ethyl (CH3CH3) 
FIGURE 11 — ISOMERIC ETIOPORPHYRINS 
Regarding Ihe slruciure of the clinically important porphyrins, coproporphyrin 
has side chains of methyl and propionic acid, and uroporphyrin has acetic acid and 
propionic acid for side chains. Again 4 isomers of each are possible, but only numbers 
I ;nul III exisl nalurally. and ihese are shown in ligure I I I , 
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Coproporphyrin I Uroporphyrin I 
A I 
M A 
(.'oproporphyrin III Uroporphyrin III 
M Methyl ICH,) P Propionic Acid ICHjCHjCOOH) A Acelic acid (CHjCOOH) 
FIGURE I I I — PROTOPORPHYRIN WITH SIDE CHAINS 
Prolo porphyrin is slightly ditlercnt in that it ha.s 3 side chains, mclhyl, vinyl 
and propionic acid and 15 isomers. The pioloporphyrin lound naturally is type 9 
and is represented in figure IV. It is so called siniplv because it was 9th in the series 
listed by Fischer. Here the parenthetical t\pc III might lead to some confusion. How-
ever, this refers only to the fact that protoporphyrin type 9 is related to type III of 
die etioporphyrins since all the methyl groups are in the same position, and this type 
111 designation is usually added lo show this relationship. 
M I 1 V 
M 
M Methyl (CHi) 
V Vinyl (CH CH,) 
P Propionic Acid 
(C HjCHiCOOH) 
M 
FIGURE IV — PROTOPORPHYRIN NO. 9 (Type III) 
164 
Treanor and Rupe 
Ha\ing now discussed individual porphyrins, we will now review the synthesis to 
determine just where porphobilinogen fits into the picture, since, although it is not 
a porphyrin, ils presence in Ihe urine eslablishcs the diagnosis of porphyria. The 
porphyrins have their origin from succinic acid of the citric acid cycle, (figure 5). 
CH,— COOH HOOC —CH,— CH?— COOH ^ 
N H z S u c c i n i c A c i d 
G l y c i n e 
N H -
I ' 
H O O C — C H — C — C H , C H , C O O H 
W ' 
o 
: i l p h a A m i n o b e t a K e t o a d i p i c 
N H , 
I 
H , C — C C H 2 — C H , C O O H 
d e l t a - A m i n o l e v u l i n i c a c i d 
FIGURE V — SYNTHESIS OF DELTA-AMINOLEVULINIC ACID 
To succinic acid is added glycine from the glycine pool and alpha-amino-beta-
ketoadipic acid is formed. This is decaraboxylaled to della-aminolevulinic acid and 
two molecules of della-aminolevulinic acid fuse lo form porphobilinogen, (figure 6). 
Della-aminolevulinic acid is not simply a stage in the path from the citric acid 
cycle lo Ihe porphyrins, bul is rather a fork in the metabolic road since il is also 
deaminated lo form ketogluteraldehyde and progresses into the purine melabolism. 
It is here lhal an enzymatic block might occur in the conversion of della-aminolevulinic 
acid into the purines with the result that more della-aminolevulinic acid could be 
forced into porphyrin synthesis at the expense of the purines.' Manifestations of 
porphyria might, iherefore, be due lo diminished purine metabolism raiher than an 
overabundance of presumably "loxic" porphyrin intermediates. To come back to 
porphobilinogen, the metabolic pathway lo this poinl is well established. However, the 
exact palhway beyond is speculative; presumably on a gross scale it may be presented 
as shown in figure VI and VI I . 
In this process thc uroporphyrin I and coproporphyrin 1 are formed as side 
products and excreted. As far as the excretion of these compounds is concerned, 
corproporphyrins are excreted in delectable amounis in the urine and stool of normal 
individuals. The normal values of corproporphvrin in urine is 100 - 300 micrograms: 
W) to 90*^ of this is in the form of isomer type I . Uroporphyrins are not excreted 
in deteclable amounts in normal persons, allhough uroporphyrin may be shown in 
a . n o 3 S , r, o' ? O C 
I 
FIGURE VI I 
SYNTHESIS c 
OF / 
PORPHOBILINOGEN C H , 
I 
N H 2 
C O O H 
I 
I 
C H , 
I 
c=o 
I 
C H , 
I 
N H , 
C H 2 
Two molecules of d e l t a - A m i n o l e v u l i n i c acid Porphobilinogen 
Porphobilinogen — — ——— ^ Uroporphyrin III ^ 
FIGURE VI I 
METABOLIC 
PATHWAYS 
BEYOND 
PORPHOBILINOGIN 
(Schematic) 
C o p r o p o r p h y r i n I I I 
Heme 4- P r o t e i n 
P r o t o p o r p h y r i n 4- I r o n 
Hemoglob in 
Catalases 
^ Oxidases 
Pe r iox idases 
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the urine by more precise melhods not readily available. Porphobilinogen is not normally 
preseni in the urine. This has great practical significance then since the diagnosis of 
porphyria for all practical purposes is made by finding Ihe uroporphyrin or porphobilin-
ogen in the urine. The Schwartz-Watson Test for porphobilinogen*' is readily available, 
and Ihis is usually positive during the acute stages of acule intermittent porphyria, and 
in some of the cases of mixed porphyria. It is not positive in porphyria erylhropoietica 
or porphyria cutanea tarda, bul il may be positive in latent porphyria. Coproporphy-
rinuria has in itself no diagnoslic value since its presence may be symptomatic and 
indicate another disease process. This will be discussed laler. 
t linically. porphyria may be defined simply as an INBORN ERROR in porphyrin 
melabolism. Various classifications have been presented but that of Walson is mosl 
widely used. Porphyria is divided into two main groups; Porphyria erylhropoietica 
and porphyria hepaiica. This classification is based upon the apparenl sile of the 
abnormal porphyrins in the bone marrow and in the liver. The porphyria hepatica 
is further subdivided into 4 groups, late porphyria, acute intermittent porphyria, 
|torph\ria cutanea tarda and mixed porphyria. 
Porphyria erylhropoietica (also called congenilal porphyria, allhough in a sense 
all the porphyrias are congenilal or inborn errors of melabolism) is the rarest of all 
the forms of porphyria and is characterized by splenomegaly and appearance earlv 
in life of sensilivily lo light with Ibe formation of skin lesions. This lypc of porphyria 
is apparenth nni lamilial, and there is no difference in the sex incidence. Red stained 
diapers may be Ihe firsi clue lo ils presence, bul usually vesicles or bullae with sun 
sensitivity are Ihe irade mark of porphyria er\'lhropoielica. These bullae become 
infected, necrotic and show deep scarring, producing severe mutilalion. and al times 
loss of fingers, iocs or cars has heen noled. Hypertrichosis is often preseni in this 
form. The abnormal prophyrins are produced in the bone marrow and the developing 
erythrocytes may show lluorescence. Uroporphyrin I and coproporphyrin 1 are found in 
the urine: porphobilinogen is not excreted. 
Porphyria hepatica is Ihe second major classification of the porphyrias. Porphyria 
hepaiica is familial and is slighth more common in women. The usual age of onset 
is 20 lo 40. Acule intermittent porphyria is the first type under this classification, 
.Mul ll may preseni wilh abdominal, neurologic or psychic symptoms in combination 
or alone. The abdominal complaints may mimic any sort of acule abdominal condition. 
1 he abilily of the porphyrin to masquerade as an acute abdominal emergency 
is allesled to by ihe number of abdominal scars which these patients may preseni. 
Index of suspicion of porphyria is lo be mulliplied for each scar in a palienl presenting 
uiih acule abdominal pain. (The pain is usually cramping in nature and, by way of 
help in ditlerentialion. allhough leucocytosis is usual, the abdomen is usually sofl 
and lenderncss is minimal). Involvemenl of the nervous system may occur in any ol 
its parts — central, peripheral or aulonomic and consequently may lake many forms. 
Ihe paralysis is of thc flaccid variety and may vary from foot or wrist drop to a 
flaccid quadriplegia. Paralysis may progress in a manner suggesting Landry's paralysis. 
Ihe Ciuillain-Barrc svndrome may be mimicked. Cerebral spinal fluid is usuallv normal 
except for minimal proiein elevation. I he cranial nerves may be attacked wilh facial 
weakness or ocular paralysis. Pain in the legs lo suggesi diabeiic neuropathy may occur 
Porphyria 
before or with the paralysis. The degree of pain will vary with the degree of peripheral 
neuritis. Despite the presence of paresthesias, sensory changes are generally absent. 
Coma, convulsions and epileptiform attacks may occur. Thc mental changes possibly 
embrace the field of psychiatry. As a matter of fact, Waldenstrom discovered most of 
his cases of porphyria by simply testing the urines of a large number of patients in 
Swedish mental hospitals. Before the acute attack comes on, the patient may have had 
a long history of psychoneurosis. 
Porphyria cutanea tarda resembles the porphyria erylhropoietica because of Ihe 
skin lesions and photosensitivity. However, the age of onset is from 40 to 60 years 
and the skin lesions, though similar, are less mutilating and hepaiic dysfunction is often 
present. If the cutaneous lesions are present in addition to neurologic or abdominal 
manifestations, then these cases are referred to as mixed porphyria: and if the patient 
appears to be well but yet excretes porphobilinogen or uroporphyrin in ihe urine, 
ihe patient is said to have latent porphyria. 
An important point must now be raised regarding porphyrinuria as opposed 
lu porphyria. It should be emphasized that the finding of an excessive amount of 
coproporphyrin in the urine does not make the diagnosis of porphyria by ilself. This 
merely represents porphyrinuria or, to be more specific, coproporphyrinuria and is 
merely a manifestation of another disease process, Coproporf. yrinuria has been found 
in a large variety of diseases such as infectious hepatitis, obstructive jaundice, pernicious 
anema, hemolytic anemia, poliomyelitis, Hodgkin's disease, Laennec's cirrhosis and in 
PORPHOBILINOGEN UROPORPIIVKINS COPROPORPHYRINS 
NORMAL NEGATIVE NEGATIVE 
I'oi.il Iiio..l0() MCO 
Type I (60-80%) 
und Type I I I 
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ERYTHROPOIETICA NEGATIVE Type I Type I 
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E 
P 
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T 
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ACUTE 
INTERMITTENT POSITIVE Type I Type I I I 
PORPHYRIA 
CUTANEA TARDA NEGATIVE Type I Type I I I 
•MIXED" 
PORPHYRIA 
MAY BE 
POSITIVE Type I Type I I I 
"LATENT-
PORPHYRIA 
INTERMITTENTLY 
POSITIVE 
Type I 
Inlermiltently 
Type HI 
Inlennittemly 
COPROPORPHYRINURIA NEGATIVE NEGATIVE Types I and IH 
TABLE I 
SUMMARY OF THE URINARY PORPHYRIN EXCRETION IN THE PORPHYRIAS 
infection processes such as pneumonia. Porphobilinogen is usually present in the 
urine of symptomatic cases of acute inlermilienl porphyria, preseni inlermillenlly 
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in latent porphyria and may be preseni in mixed porphyria, l l is not preseni in porphyria 
cutanea tarda and porphyria erylhropoietica. All the forms of porphyria hepaiica 
may show coproporph\rin III and a uroporph\rin which is usually referred to as 
\\-iKkiislrom's uroporph\'rin and is probably uroporphyrin tvpe I , allhough il is claimed 
by oihers to be type I I I . Uroporphyrin I is found in the urine of porphyria erylhro-
poietica. Regarding the color of the urine, grossly, it is usually thought thai lhc urine 
musl he colored lo suggesi a diagnosis; though actually porphobilinogen is colorless 
and the oiher porphyrins excreted will color urine only when excreted in large quantities 
such as in porphyria erylhropoietica. From a practical standpoint then, a normal 
colored urine does not exclude ihe diagnosis of porphyria. 
From the standpoint of irealmeni, splenectomy and protection from the sun 
in the porphyria erylhropoietica are indicated, and screening from the sun would be 
indicaled in Ihe porphyria cutanea larda. For the varied manifeslalions of acute 
intermittent porphyria in Ihc form of abdominal neurologic or psychic symptoms, 
a wide variety of agents has been tried, and il is probabK more important lo know 
whal noi to give these palienis. Alcohol and barbiiurales are definilely coniraindicated 
since ihcy have been reported to precipitate an episode of porphyria.* For the relief 
ot p.iin and sedation. Demerol. Chloral Hydrate and Paraldehyde are effeclive and 
apparenlh do no harm. At various limes iniravenous calcium, crude Hver extract. 
relraelh\l-ammonium Chloride, Corlisone and ACTH have been recommended, all 
wilh varying degrees of success. Chlorpromazine has recently been reported to be 
helplul.' SchrumpF and Pelers' have reporied good results in Ihe Irealmeni of acule 
inlermilienl porphyria wilh BAL (Dimcrcaprol). Peters noted in some of his cases 
thai an increased amouni of zinc was preseni in the urine. BAL was given in an 
aiK'inpi to aid in the excrelion of the zinc. The chelating agent disodium calcium 
versenaie has been recommended and apparently may be ciTeclive on a similar process. 
An increased amount of zinc may be important in producing an enzyme lesion 
possibly by blocking to some exlenl the transformation of the porphobilinogen lo 
the purines. BAL was chosen as ihe agent lo he iried in the case of acule intermittent 
porphyria now to he discussed. 
I ' . i i ifni (I I I ) a 43 ycur old. wliik- liinisewifi; w;is ailniillod lo anollier hospiUil on February 
9, compliimin)' of mill abdominal pain which had been present for 2 diiys and wns .issociatcd 
wilh nausea and tonslipation. The pasl medical history was negative. Thc pain persisted for 6 days, 
requiring narcoiics at regular iniervals. The pain disappeared then bul was followed by developmeni 
of pain in llie legs and progressive weakness of the arms and legs. A Walson lest for porphobilinogen 
was positive and the patient was transferred lo Henry Ford flospiial on February 21, 1957. 
Ihe physical examination on admillance here was normal cicepl for the neurologic findings. 
The palienl w.as exiremely lethargic. She would respond briefly lo questioning but was unable lo 
remain alert for any susiained period. There was a flaccid quadriplegia. and brain stem involvemenl 
was preseni »iih facial diplegia, ocular weakness and dysphagia. Sensaiion appeared intact. 
On admission ihe urine was dark brown, gave a yellowish green fluorescence under a Wood's 
lamp and was posilivc for porphobdinoiicn The hemoglobin was 12,8 grams, while count 12.200. 
Spinal fluid wa* negative except for slightly elevated protein of 57 mgm'~f. No cells were seen in 
ihe spmal fluid. An electroencephalogram showed a dilTuse depression of ciccirical .ictivily. Skull 
K-rayx were negative. 
Ihc palienl was siarlcd on BAI, in a dose of 100 mgm every eight hours on February 23, 1957. 
An elective tracheotomy wa.s done for retained secretions, and the patient was also begun on tube 
fccdmg via the Barron pump. Wilhin 24 hours the paticni was able to converse with ine allending 
physician* and even Mated a desire lo go home, allhough lhc paralysis remained as before. She 
rcm.imed on HAI. uniil March 15. 1957. During this period she was also given Chlorpromazine 
25 mgm every 6 hours, as neceitsnry. for moderate cMremity pain which she was experiencing. The 
muscle power in the extremities gradually improved until discharged on April 13, 1957. At lhat 
1 
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ime the paiieni was getting oui of bed in a chair for short periods and was noling increasing 
ibilily to move lhc extremities and had begun to feed herself. 
The imporlanl aspecls of physiolhcrapy and measures for rchabiliiaiion in this palienl were 
. anducted throughout her hospital slay by Dr. William Schaefer and his siaft' in lhc Division of 
I'hysigal Medicine and Rehabilitation. 
Other laboralory dala accumulaied during lhc palienl's illness were reported as follows: 
cphalin cholesicrol I plus, ihymol lurhidily 1 plus, ihymol floculation negalive. zinc sulfate 7 unils_ 
i^ r^um sodium 128 milli-equivalents per liter, serum chloride 106 milli-cquivalenis per liter, uric 
icid on two occasions was 1.3 mgm and 2.2 mgm '"f and a 24 hour urine uric acid was 547 mgm 
I normal equals 500 mgm lo 101)0 mgm a day). The low figures for serum uric acid and 24 hour 
Liric acid excrelion lends some credence lo Ihc hypothesis lhat porphyria represenis a block in the 
I inversion of dclia-aminolcvulinic acid melabolism towards lhc purine metabolism. USP showed 
T"<- retention at 45 minuies. serum bilirubin a total of 0.5 mgm '^r. direcl 0.125 mgm Thc 
':-d rate was 2. Urinalysis was negalive, non-proiein niirogen 28 mgm ' ^ i , direcl and indirect Coombs 
i.sis were negalive, prothrombin lime 16 seconds 90'^;. rcliculocyle count 6*"^ . Elccirocardiograph 
^ .IS normal excepi for sinus tachycardia, and chesl x-rays were negalive. 
On r-ebruary 25. 1957, Ihe 24 hour urine conlaincd 21.8 mgm of jiorphobilinogcii. 6000 micro-
i.ims of coproporphyin and 1750 micrograms of uroporphyrin. Daily quaniiialive determinations 
. [ porphobilinogen and coproporphyrin were done unlil March 2, 1957_ and the quaniiiy of ihesc 
i.vo compounds fell slowly so thai on March 2nd ihe urine contained only 1.8 mgm of porpho-
i ilinogcn and 1.680 micrograms of coproporphyrin. No funher dclerminaiions of coproporphyrin 
\\cre made, hui ihe quaniily of porphobilinogen eoniinued lo fall until i l was absenl wilhin three weeks 
(ilier admission and remained absent for ihe remainder of her hospital course. The urine color 
V,tried from dark brown lo light straw. There was no appreciable change wilh exposure to light. 
A niece of the palienl gave a hislory of a very similar illness diagnosed as acuie inlermiitcnl 
]• irphyria several years ago. The niece furnished a 24 hour urine for tesing. and it gave a positive 
Kaction for porphobilinogen. The niece had no symploms al lhat lime, hul inlercMingly enough. 
Ilie patient who was bedridden by the same disorder was Ihcn passing urine which was negative lor 
I'lirphobilinogen, 
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